SHAIK MOHAMMED MONSOOR

Shaik, M., Ami, D., Romerio, A., Gagliano, C., Palmer, C., Aladailleh, Z., et al. (2026). Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties. CHEMICAL ENGINEERING JOURNAL ADVANCES, 25(March 2026) [10.1016/j.ceja.2026.101053]. Dettaglio

Italia, A., Franco, A., Shaik, M., Romerio, A., Lami, F., Lovisa, S., et al. (2025). Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases. In Convegno Nazionale della Divisione di Chimica dei Sistemi Biologici 2025. Trieste 18-20 Giugno 2025. Book of abstracts (pp.68-68). Dettaglio

Romerio, A., Shaik, M., Italia, A., Lami, F., Galimberti, M., Peri, F. (2025). Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants. Intervento presentato a: 3° Convegno Nazionale della Divisione di Chimica dei Sistemi Biologici - 18 - 20 Giugno 2025, Trieste, italy. Dettaglio

Franco, A., Aladailleh, Z., Romerio, A., Italia, A., Lami, F., Shaik, M., et al. (2025). Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists. RSC MEDICINAL CHEMISTRY, 16(5), 2261-2269 [10.1039/D4MD00950A]. Dettaglio

Ami, D., Franco, A., Artusa, V., Romerio, A., Shaik, M., Italia, A., et al. (2024). Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists. TALANTA, 275(1 August 2024) [10.1016/j.talanta.2024.126104]. Dettaglio